LSAF LeaderShares AlphaFactor US Core Equity ETF

Expense Ratio
0.75%
Dividend
0.57%
Previous close
$53.84
Est. 12 months change
+18.45%
Projected Price
$63.78

Profitability Metrics

Return on Equity (ROE)
31.16%
Return on Assets (ROA)
7.35%
Return on Invested Capital (ROIC)
28.37%
Weighted Average Cost of Capital (WACC)
7.79%
ROIC - WACC
20.58%
Updated : 2026-10-07 22:33 ET

Valuation Metrics

P/E Ratio
14.35
Forward P/E
12.23
PEG Ratio
1.78
Debt Current Ratio
2.83

Growth & Cash Flow

Gross Margin
46.17%
Operating Margin
12.31%
FCF Margin
19.31%
TTM Revenue Growth
13.97%
Projected 12M EPS Growth
17.35%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NA1.92%
LAD1.05%
AN1.03%
MPC1.03%
MCK1.02%
USFD1.02%
DINO1.02%
GWRE1.02%
FTV1.01%
R1.01%

ETF Analysis

Fund Overview

LeaderShares AlphaFactor US Core Equity ETF (LSAF) currently reports 101 stock positions (subject to change), placing it in the broad-based range by holdings breadth. The top line-up is NA (1.92%), LAD (1.05%), AN (1.03%), with NA as the largest single weight at 1.92%. Together, the top three holdings account for 4.00%, which does not represent a dominant share, indicating less concentration in the very top of the book. The overall construction balances concentrated exposure at the top with broader diversification through the rest of the book.

Profitability & Capital Efficiency

Through the lens of capital efficiency, ROIC is 28.37%, WACC is 7.79%, and the economic spread is 20.58%. On balance, the gap between operating returns and funding costs is healthy, pointing to businesses with genuine pricing and reinvestment advantages. Supporting metrics show ROE at 31.16% and ROA at 7.35%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Assessed on a multiple basis, trailing P/E of 14.35, forward P/E of 12.23, PEG of 1.78. Forward P/E tracks closely with trailing P/E — a sign that the market sees the current earnings run rate as a reasonable baseline going forward. Growth-adjusted, the multiple is in an acceptable range — the portfolio is neither pricing in perfection nor offering a meaningful valuation discount. The portfolio's weighted current ratio of 2.83 signals strong near-term financial resilience. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

Margins & Cash Generation

The margin profile breaks down as follows: gross margin sits at 46.17%, operating margin at 12.31%, and free cash flow margin at 19.31%. Gross margins are in good shape, suggesting the holdings maintain pricing discipline at the revenue-to-cost interface. Operating margins are modest, suggesting overhead costs are consuming a meaningful share of gross profit. The portfolio's FCF margin is healthy, indicating solid cash conversion after capital expenditure needs. The mixed margin profile here calls for selectivity — the portfolio's quality of earnings is not uniform across the holding set.

Growth & Forward Outlook

The growth and outlook picture reads as follows: TTM revenue growth of 13.97% pointing to reasonable revenue execution across the underlying holdings. In parallel, analysts project moderate appreciation over the next 12 months based on current consensus targets. The gap between trailing fundamentals and forward expectations matters most at inflection points — and the current environment is not without those. For long-term holders, the central question is whether today's execution quality is a leading indicator of what's already priced into analyst targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Reviewed in aggregate, this is a high-quality profile with few clear structural weaknesses — a combination that historically tends to support above-average long-term outcomes.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.